TAKEDA PHARM.CO.LTD./ JP3463000004 /
09/08/2024 22:59:57 | Var. +0.070 | Volume | Denaro22:59:57 | Lettera22:59:57 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
25.380EUR | +0.28% | - Fatturato: - |
25.380Quantità in denaro: - | 25.790Quantità in lettera: - | 39.58 bill.EUR | - | - |
Newsfile Corp
02:36
Cayman Islands Based Pam Ebanks-Small on Coffee With Q - Empowering the Next Generation of Women
Newsfile Corp
02:25
NETA Auto's R&D Center Opens in Hong Kong: Leading the Smart Automotive Innovation Ecosystem as a "C...
Newsfile Corp
01:55
TDC DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Teradata Corporation Investors to S...
Newsfile Corp
01:25
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages FutureFuel Corp. Investors to Secure Counsel Before I...
Newsfile Corp
01:19
RBLX DEADLINE MONDAY: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Roblox Corporation to ...
Newsfile Corp
00:48
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DXC Technology Company Investors to Secure Counsel Befor...
Newsfile Corp
00:36
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Five Below, Inc. Investors to Secure Counsel Before Impo...
Newsfile Corp
00:12
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Be...
Newsfile Corp
00:00
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Befor...